Mostrar el registro sencillo del ítem

dc.contributor.authorPeralta M
dc.contributor.authorLizcano F.
dc.date.accessioned2024-11-01T14:34:44Z
dc.date.available2024-11-01T14:34:44Z
dc.date.issued2024
dc.identifier.issn1530891X
dc.identifier.otherhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85184039039&doi=10.1016%2fj.eprac.2024.01.006&partnerID=40&md5=d898fb2ab343d7ab702efb15487b87c7
dc.identifier.urihttp://hdl.handle.net/10818/62205
dc.description.abstractObjective: This study aims to explore the significant impact of environmental chemicals on disease development, focusing on their role in developing metabolic and endocrine diseases. The objective is to understand how these chemicals contribute to the increasing prevalence of precocious puberty, considering various factors, including epigenetic changes, lifestyle, and emotional disturbances. Methods: The study employs a comprehensive review of descriptive observational studies in both human and animal models to identify a degree of causality between exposure to environmental chemicals and disease development, specifically focusing on endocrine disruption. Due to ethical constraints, direct causation studies in human subjects are not feasible; therefore, the research relies on accumulated observational data. Results: Puberty is a crucial life period with marked physiological and psychological changes. The age at which sexual characteristics develop is changing in many regions. The findings indicate a correlation between exposure to endocrine-disrupting chemicals and the early onset of puberty. These chemicals have been shown to interfere with normal hormonal processes, particularly during critical developmental stages such as adolescence. The research also highlights the interaction of these chemical exposures with other factors, including nutritional history, social and lifestyle changes, and emotional stress, which together contribute to the prevalence of precocious puberty. Conclusion: Environmental chemicals significantly contribute to the development of certain metabolic and endocrine diseases, particularly in the rising incidence of precocious puberty. Although the evidence is mainly observational, it adequately justifies regulatory actions to reduce exposure risks. Furthermore, these findings highlight the urgent need for more research on the epigenetic effects of these chemicals and their wider impact on human health, especially during vital developmental periods. © 2024 AACEen
dc.formatapplication/pdfes_CO
dc.language.isoenges_CO
dc.publisherEndocrine Practicees_CO
dc.relation.ispartofseriesEndocrine Practice Vol. 30 N° 4
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabanaes_CO
dc.sourceIntellectum Repositorio Universidad de La Sabanaes_CO
dc.subject.other4,4' Isopropylidenediphenolen
dc.subject.otherAtrazineen
dc.subject.otherChlorphenotaneen
dc.subject.otherEndocrine disruptoren
dc.subject.otherEnvironmental chemicalen
dc.subject.otherEstrogenen
dc.subject.otherGonadorelinen
dc.subject.otherKisspeptinen
dc.subject.otherPhthalic aciden
dc.subject.otherPolychlorinated biphenylen
dc.titleEndocrine disruptors and metabolic changes: impact on puberty controlen
dc.typejournal articlees_CO
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.1016/j.eprac.2024.01.006


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International